| Nanoparticle delivery of chemosensitizers improve chemotherapy efficacy without incurring additional toxicity JM Caster, M Sethi, S Kowalczyk, E Wang, X Tian, SN Hyder, KT Wagner, ... Nanoscale 7 (6), 2805-2811, 2015 | 43 | 2015 |
| Lin28a regulates pathological cardiac hypertrophic growth through Pck2-mediated enhancement of anabolic synthesis H Ma, S Yu, X Liu, Y Zhang, T Fakadej, Z Liu, C Yin, W Shen, ... Circulation 139 (14), 1725-1740, 2019 | 40 | 2019 |
| Sarcopenia as a predictor of survival and chemotoxicity in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy SA Staley, K Tucker, M Newton, M Ertel, J Oldan, I Doherty, L West, ... Gynecologic oncology 156 (3), 695-700, 2020 | 33 | 2020 |
| Malignant Brenner tumor of the ovary: Case series and review of treatment strategies Y Zhang, SA Staley, K Tucker, LH Clark Gynecologic Oncology Reports 28, 29-32, 2019 | 28 | 2019 |
| ErbB2 is required for cardiomyocyte proliferation in murine neonatal hearts H Ma, C Yin, Y Zhang, L Qian, J Liu Gene 592 (2), 325-330, 2016 | 19 | 2016 |
| Formulation of diblock polymeric nanoparticles through nanoprecipitation technique S Karve, ME Werner, ND Cummings, R Sukumar, EC Wang, YA Zhang, ... JoVE (Journal of Visualized Experiments), e3398, 2011 | 19 | 2011 |
| ONC206, an Imipridone Derivative, Induces Cell Death Through Activation of the Integrated Stress Response in Serous Endometrial Cancer In Vitro Y Zhang, Y Huang, Y Yin, Y Fan, W Sun, X Zhao, K Tucker, A Staley, ... Frontiers in Oncology 10, 577141, 2020 | 16 | 2020 |
| Clinical characteristics of CNS metastases from primary gynecologic cancers Y Zhang, MS Grant, WH Stepp, LH Clark Gynecologic Oncology Reports 30, 100518, 2019 | 15 | 2019 |
| Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer A Staley, K Tucker, Y Yin, X Zhang, Y Fan, Y Zhang, Z Fang, W Sun, ... American Journal of Cancer Research 11 (11), 5374, 2021 | 11 | 2021 |
| Comparing laparotomy with robot-assisted interval debulking surgery for patients with advanced epithelial ovarian cancer receiving neoadjuvant chemotherapy Y Zhang, MS Grant, X Zhang, SE Paraghamian, X Tan, LH Clark Journal of Minimally Invasive Gynecology 28 (6), 1237-1243, 2021 | 8 | 2021 |
| Ipatasertib, an oral AKT inhibitor, inhibits cell proliferation and migration, and induces apoptosis in serous endometrial cancer L Buckingham, T Hao, J O’Donnell, Z Zhao, X Zhang, Y Fan, W Sun, ... American Journal of Cancer Research 12 (6), 2850, 2022 | 6 | 2022 |
| Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival DM Gershenson, LP Cobb, SN Westin, Y Zhang, A Jazaeri, A Malpica, ... Gynecologic oncology 167 (2), 139-145, 2022 | 5 | 2022 |
| A multi-institutional study of minimally invasive surgery compared to laparotomy for interval debulking after neoadjuvant chemotherapy in women with advanced ovarian cancer J Brown, A Barr, Y Zhang, B Davidson, AA Secord, L Drury, E Crane, ... Gynecologic Oncology 162, S20, 2021 | 3 | 2021 |
| Outpatient panniculectomy and skin graft for adult buried penis BD Figler, ZS Gan, CS Mohan, Y Zhang, P Filippou Urology 143, 255-256, 2020 | 2 | 2020 |
| Clinical and genomic landscape of RAS pathway mutations in gynecologic cancers. J Son, Y Zhang, M Nardo, O Mirallas, RT Hillman, HY Lin, E Campbell, ... Journal of Clinical Oncology 41 (16_suppl), 5611-5611, 2023 | 1 | 2023 |
| Ichthyosis uteri: A keratinizing squamous metaplasia of the endometrium with premalignant potential Y Zhang, S Tounsi, G Yadav, RP Masand, AB Costales Gynecologic Oncology Reports 46, 2023 | 1 | 2023 |
| Khorana score stratification and incidence of venous thromboembolism among women with ovarian cancer receiving neoadjuvant chemotherapy J Salinaro, Y Zhang, L Buckingham, L Clark, L Havrilesky, B Davidson Gynecologic Oncology 162, S194, 2021 | 1 | 2021 |
| A comparison of postoperative morbidity in open versus robotic-assisted interval debulking surgery for epithelial ovarian cancer patients following neoadjuvant chemotherapy Y Zhang, A Staley, K Tucker, SE Paraghamian, M Wang, LH Clark Gynecologic Oncology 154, 138, 2019 | 1 | 2019 |
| Clinical and genomic landscape of RAS mutations in gynecologic cancers J Son, Y Zhang, H Lin, O Mirallas, P Alvarez Ballesteros, M Nardo, ... Clinical Cancer Research, 2024 | | 2024 |
| Delayed publication of clinical trials in gynecologic oncology JR Salinaro, EC Rossi, KN Penvose, Y Zhang, AJ Darling Gynecologic Oncology 183, 74-77, 2024 | | 2024 |
Chunxiao ZhouUniversity of North Carolina at Chapel HillVerified email at med.unc.edu
